InvestorsHub Logo
Followers 66
Posts 12725
Boards Moderated 0
Alias Born 06/03/2015

Re: XenaLives post# 96774

Tuesday, 03/21/2017 12:59:44 PM

Tuesday, March 21, 2017 12:59:44 PM

Post# of 462417
I believe the new Plus formulation (lower dose of donepezil) is the basis for Anavex's latest appeal to the USPTO for the Plus patent. Where the lower dose (5mg) is the optimal amount to combine with 2-73, which would not be obvious by one who's knowledgeable in the art.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News